Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate

Details for Australian Patent Application No. 2008228714 (hide)

Owner Bristol-Myers Squibb Company

Inventors Tejwani, Ravindra W.; Vatsaraj, Nipa; Bindra, Dilbir S.; Patel, Jatin M.; Dali, Mandar V.; Wu, Yongemei; Parab, Prakash V.; Tao, Li

Agent A J Park

Pub. Number AU-A-2008228714

PCT Pub. Number WO2008/116179

Priority 60/896,286 22.03.07 US

Filing date 21 March 2008

Wipo publication date 25 September 2008

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/116179 Priority application(s): WO2008/116179

5 November 2009 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor from Wu, Yongemei to Wu, Yongmei

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008228722-Systems and methods for anaerobic environmental microbial compartmentalized cultivation

2008228710-Segmented intramedullary structure